Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: Neurobiol Dis. 2025 May 2;212:106936. doi: 10.1016/j.nbd.2025.106936

Fig. 3.

Fig. 3.

Validation of quantitative mass spectrometry analysis. The western blotting analysis demonstrates the brain expression level of protein candidates, 14–3-3 (pan) and 14–3-3 gamma isoform, in aged male subjects (A) and aged female subjects (B) after ICH or sham. (C & D) and (E &F) illustrate the densitometry analysis of the western blotting data normalized against beta-actin from aged male and female subjects, respectively (n = 4–5/group).